Generics

RK Pharma said the acquisition will give the company an exciting product portfolio, meaningful partnerships and a proven team with an impressive track record.

AbbVie accused Coherus of breaching a previous agreement, granting a license for a biosimilar of Humira, leading Coherus to file a restraining order to prevent termination of the licensing deal.

The plan highlights the most critical challenges preventing patient access to biosimilar medicines, as well as actionable steps to accelerate adoption by overcoming those challenges.

Neostigmine Methylsulfate injection is indicated for the reversal of the effects of nondepolarizing neuromuscular blocking agents after surgery.

Upsher-Smith won for best overall branded pharmaceutical product manufacturer in its sales category.

Pemrydi is the first ready-to-use presentation of key injectable for treating non-squamous non-small cell lung cancer and malignant pleural mesothelioma.

Dexlansoprazole is a proton pump inhibitor approved for the treatment of erosive esophagitis and heartburn associated with certain causes.

The injection is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of adults with cardiac decompensation due to specific factors.